The specialist integrated CDMO

Browser not supported

Oops! Your browser version is not supported by our website.
Please use these following browsers to view this page:

Google Chrome
Safari
Firefox
Edge
© 2025 Hovione
  • Linkedin
  • Facebook
  • Twitter
  • Instagram
  • Youtube
search
    en
      pt jp cn
Hovione
Home Go up
  • Products and Services
      • Contract Manufacturing Services
        • Drug Substance
        • Particle Engineering
        • Drug Product
      • Off-patent API products
        • API Portfolio
        • Exclusive partnerships
        • High value applications
      • Supporting Capabilities
        • Analytical Support
        • Capabilities
        • Continuity of Supply
        • Quality and Compliance
  • Knowledge Center
  • About Us
      • About Hovione
        • What we do
        • Management
        • Sustainability
        • History
  • Contact Us
  • Press Room
  • Hovione Worldwide
  • Careers
  • Restricted Area

Search

Types

  • Article

Press Room

  • Press Clipping
  • Press Release

Categories

  • Hovione Cork
  • Hovione Japan
  • Hovione Lumiar
  • Hovione New Jersey
  • Contract Manufacturing Services
  • DP - Inhalation formulation
  • DPI
  • Hovione Mumbai
  • asd-hipros
  • Compliance
  • Continuous Flow
  • Continuous Manufacturing
  • Continuous Tableting
  • Development by Design
  • Dispersome
  • DP - Capsule filling
  • DP - DPI devices
  • Homepage
  • Hovione Switzerland
  • Integrated Offering
  • PE - Drug delivery platforms
  • PE - Inhalable particles
  • PE - Spray drying
  • Quality
  • Quality by Design
  • (-) Devices
  • (-) DP - Drug product
  • (-) Hovione Loures
View
Event

Webinar - Nasal powder delivery: Process, formulation and analytical characterization

Date: 2023/11/30
Location: Online
View
Press Release / Mar 07, 2023

Hovione receives the 2023 CDMO Leadership Award in all six categories and is Champion in Compatibility and Expertise

Hovione won the 2023 CDMO Leadership Award across all six categories across all three groups of respondents

Sunriser® DPI

High Performance, High-Dose Capsule DPI.

View
Press Clipping / May 03, 2023

Hovione and Presspart extend technology partnership

Manufacturing Chemist, 3 May 2023

Analytical Support
Quality and Compliance
Capabilities
Continuity of Supply
Track Record/cGMP Compliance
Regulatory Affairs
Continuity of Supply
  • Hovione Worldwide
  • Events
  • Press Room
  • Careers
  • Customers
  • Suppliers
Contacts
Lindenstrasse 14
6340 Baar
Switzerland
  • Linkedin
  • Facebook
  • Twitter
  • Instagram
  • Youtube
  • Privacy Notice
  • Terms and Conditions
    • Linkedin
    • Facebook
    • Twitter
    • Instagram
    • Youtube
  • Hovione Worldwide
  • Events
  • Press Room
  • Careers
  • Customers
  • Suppliers
  • Contacts
    Lindenstrasse 14
    6340 Baar
    Switzerland
    © 2025 Hovione
    © 2025 Hovione
    • Privacy Notice
    • Terms and Conditions